Cargando…

Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease

For many patients with sickle cell disease (SCD), jaundice is a significant clinical disease manifestation that impacts on patient well-being. We report a case of a patient with SCD and chronic jaundice treated with voxelotor (GBT440), a novel small molecule hemoglobin oxygen affinity modulator and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Telfer, Paul, Agodoa, Irene, Fox, Kathleen M., Burke, Laurie, Mant, Timothy, Jurek, Marzena, Tonda, Margaret, Lehrer-Graiwer, Josh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036983/ https://www.ncbi.nlm.nih.gov/pubmed/30046415 http://dx.doi.org/10.4081/hr.2018.7643

Ejemplares similares

Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease
por: Hutchaleelaha, Athiwat, et al.
Publicado: (2019)

GBT440 Inhibits Sickling of Sickle Cell Trait Blood Under In Vitro Conditions Mimicking Strenuous Exercise
por: Dufu, Kobina, et al.
Publicado: (2016)

The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease
por: Minniti, Caterina P., et al.
Publicado: (2021)

GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro
por: Dufu, Kobina, et al.
Publicado: (2018)

Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment
por: Preston, Richard A., et al.
Publicado: (2020)

Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
por: Metcalf, Brian, et al.
Publicado: (2017)

Voxelotor: A Ray of Hope for Sickle Disease
por: AlDallal, Salma M
Publicado: (2020)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
por: Achebe, M, et al.
Publicado: (2022)

Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study
por: Brown, Clark, et al.
Publicado: (2023)

Unconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption
por: Zhao, Chong, et al.
Publicado: (2021)

Revalidation and rationale for high pKa values of unconjugated bilirubin
por: Ostrow, J Donald, et al.
Publicado: (2007)

Unconjugated bilirubin induces pyroptosis in cultured rat cortical astrocytes
por: Feng, Jie, et al.
Publicado: (2018)

Fluorescent protein-based detection of unconjugated bilirubin in newborn serum
por: Iwatani, Sota, et al.
Publicado: (2016)

Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action
por: Green, Michelle L., et al.
Publicado: (2022)

Patient perception of voxelotor treatment benefit in sickle cell disease
por: Idowu, Modupe, et al.
Publicado: (2022)

Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell Disease
por: Barriteau, Christina M, et al.
Publicado: (2022)

The Evolving Landscape of Neurotoxicity by Unconjugated Bilirubin: Role of Glial Cells and Inflammation
por: Brites, Dora
Publicado: (2012)

Unconjugated Bilirubin Exposure Impairs Hippocampal Long-Term Synaptic Plasticity
por: Chang, Fang-Yu, et al.
Publicado: (2009)

Neurotoxicity of Unconjugated Bilirubin in Neonatal Hypoxic-Ischemic Brain Injury in vitro
por: Dani, Carlo, et al.
Publicado: (2021)

Physico-chemical characterization of bilirubin-10-sulfonate and comparison of its acid–base behavior with unconjugated bilirubin
por: Čepa, Adam, et al.
Publicado: (2021)

Voxelotor: A Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease
por: Yenamandra, Avani, et al.
Publicado: (2020)

P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
por: Konté, Kadère, et al.
Publicado: (2023)

Unconjugated bilirubin ameliorates the inflammation and digestive protease increase in TNBS-induced colitis
por: Zhou, Jin-An, et al.
Publicado: (2017)

Rheological Impact of GBT1118 Cessation in a Sickle Mouse Model
por: Kanne, Celeste K., et al.
Publicado: (2021)

Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice
por: Ren, Guohui, et al.
Publicado: (2022)

Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe
por: Ferlis, Mica, et al.
Publicado: (2022)

Modeling the public health impact of voxelotor in the management of sickle cell disease in France
por: Galacteros, Frédéric, et al.
Publicado: (2023)

The GBT Project
por: Moreira, P, et al.
Publicado: (2009)

Exposure to Lipopolysaccharide and/or Unconjugated Bilirubin Impair the Integrity and Function of Brain Microvascular Endothelial Cells
por: Cardoso, Filipa L., et al.
Publicado: (2012)

Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor
por: Glaros, Alexander K., et al.
Publicado: (2021)

Low solubility of unconjugated bilirubin in dimethylsulfoxide – water systems: implications for pK(a) determinations
por: Mukerjee, Pasupati, et al.
Publicado: (2002)

Evaluation of Treatment Thresholds for Unconjugated Hyperbilirubinemia in Preterm Infants: Effects on Serum Bilirubin and on Hearing Loss?
por: Hulzebos, Christian V., et al.
Publicado: (2013)

Unconjugated Bilirubin exerts Pro-Apoptotic Effect on Platelets via p38-MAPK activation
por: NaveenKumar, Somanathapura K., et al.
Publicado: (2015)

Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation
por: Zheng, Jia-Dong, et al.
Publicado: (2019)

Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
por: Sykora, Tomas, et al.
Publicado: (2021)

Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
por: Migotsky, Michael, et al.
Publicado: (2022)

5610417 IN-VITRO REAL-TIME OBSERVATION OF MODERATE SICKLING KINETICS IN SICKLE ERYTHROCYTES TREATED BY VOXELOTOR UNDER MONOTONIC AND CYCLIC HYPOXIA
por: Qiang, Y.Q., et al.
Publicado: (2023)

Interactions of unconjugated bilirubin with vesicles, cyclodextrins and micelles: New modeling and the role of high pKa values
por: Mukerjee, Pasupati, et al.
Publicado: (2010)

Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood-brain barrier lining
por: Palmela, Inês, et al.
Publicado: (2012)

Relation between unconjugated bilirubin and RDW, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio in Gilbert’s syndrome
por: Sarlak, Hakan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s735g9qrugtds8sslvm2dn4c0r